Boston Scientific Japan Obtains Approval For Coronary Stent System
This article was originally published in PharmAsia News
Executive Summary
Boston Scientific Japan announced Jan. 29 that it obtained manufacturing and marketing approval for Taxus Liberte paclitaxel-eluting coronary stent system on Jan. 28. This is the company's second stent product approved in Japan, and previously received approval for the Taxus Express coronary stent system; Taxus Liberte has an enhanced stent delivery system. (Click here for more - Japanese language